Osteoporosis International

, Volume 16, Issue 4, pp 411–416

Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD

  • Morten M. Villadsen
  • Mathias H. Bünger
  • Mette Carstens
  • Liselotte Stenkjær
  • Bente L. Langdahl
Original Article

Abstract

Osteoporosis is a common disease with a strong genetic component. Linkage studies have suggested linkage between BMD and loci on chromosome 1. The MTHFR gene is located on chromosome 1. MTHFR catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methylenetetrahydrofolate, which is used for homocysteine methylation to methionine. The rare genotype (TT) of the C677T polymorphism has previously been demonstrated to be associated with increased plasma homocysteine levels in individuals with inadequate plasma folate levels. Recently, the TT genotype has been found to be associated with reduced bone mass. We therefore examined if the C677T polymorphism in the MTHFR gene is associated with changes in bone mass and risk of osteoporotic fractures in 388 osteoporotic patients and 336 normal individuals. The distributions of the genotypes CC, CT and TT in women with osteoporotic vertebral fractures and normal controls were 43.5%, 42.2% and 14.3% and 52.0%, 42.0% and 8.0%, respectively, χ2=5.62, P=0.06. Since studies of the functionality of this polymorphism have revealed that only the TT genotype is associated with biochemical changes, we also compared the prevalence of the TT genotype versus the CT- and CC genotypes in patients and controls and found that the TT genotype is significantly more common in women with vertebral fractures (14.3%) compared with normal controls (8.0%), χ2=4.31, P<0.05. Logistic regression analysis demonstrated that vertebral fractures were significantly associated with BMD (lumbar spine) and height but only marginally with the MTHFR genotype (P=0.06). Multiple linear regression analysis revealed that weight, age and the MTHFR polymorphism were predictors of lumbar spine BMD in women. However, age- and gender-corrected BMD of the lumbar spine and the hip was not significantly different between MTHFR genotypes. Furthermore, individuals with the TT genotype did not have BMD significantly lower than the combined group of individuals with the CT- or CC genotypes. In conclusion, we have demonstrated that the rare TT genotype of the C677T polymorphism in the MTHFR gene is associated with increased risk of osteoporotic fractures in women and a weak predictor of lumbar spine BMD.

Keywords

BMD C677T polymorphism MTHFR 

References

  1. 1.
    Pocock NA, Eisman JA, Hopper JL et al. (1987) Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80:706–710PubMedGoogle Scholar
  2. 2.
    Devoto M, Specchia C, Li HH et al. (2001) Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. Hum Mol Genet 10:2447–2452CrossRefPubMedGoogle Scholar
  3. 3.
    Devoto M, Shimoya K, Caminis J et al. (1998) First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet 6:151–157CrossRefPubMedGoogle Scholar
  4. 4.
    Goyette P, Sumner JS, Milos R et al. (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7:195–200Google Scholar
  5. 5.
    Miyao M, Morita H, Hosoi T et al. (2000) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 66:190–194CrossRefPubMedGoogle Scholar
  6. 6.
    Mudd SH, Skovby F, Levy HL et al. (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37:1–31PubMedGoogle Scholar
  7. 7.
    Frosst P, Blom HJ, Milos R et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113PubMedGoogle Scholar
  8. 8.
    Dekou V, Whincup P, Papacosta O et al. (2001) The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study. Atherosclerosis 154:659–666CrossRefPubMedGoogle Scholar
  9. 9.
    Geisel J, Zimbelmann I, Schorr H et al. (2001) Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med 39:698–704PubMedGoogle Scholar
  10. 10.
    Passaro A, Vanini A, Calzoni F et al. (2001) Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 157:175–180CrossRefPubMedGoogle Scholar
  11. 11.
    Lubec B, Fang-Kircher S, Lubec T et al. (1996) Evidence for McKusick’s hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315:159–162CrossRefPubMedGoogle Scholar
  12. 12.
    Abrahamsen B, Madsen JS, Tofteng C et al. (2003) A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 18:723–729PubMedGoogle Scholar
  13. 13.
    Genant HK, Grampp S, Gluer CC et al. (1994) Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 9:1503–1514Google Scholar
  14. 14.
    Brixen K, Nielsen HK, Hermann AP, Kjeldsen S, Charles P, Mosekilde L (1955) Bone mineral measurements in normal Danish women and men. Calcif Tissue Int 56:489Google Scholar
  15. 15.
    Risteli J, Elomaa I, Niemi S et al. (1993) Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 39:635–640PubMedGoogle Scholar
  16. 16.
    Brixen K, Nielsen HK, Eriksen EF et al. (1989) Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int 44:93–98PubMedGoogle Scholar
  17. 17.
    Nielsen HK, Laurberg P, Brixen K et al. (1991) Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone, and ionized calcium in normal individuals. Acta Endocrinol 124:391–398PubMedGoogle Scholar
  18. 18.
    Melkko J, Niemi S, Risteli L et al. (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328–1332PubMedGoogle Scholar
  19. 19.
    Kunkel LM, Smith KD, Boyer SH et al. (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245–1249PubMedGoogle Scholar
  20. 20.
    Jorgensen HL, Madsen JS, Madsen B et al. (2002) Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women. Calcif Tissue Int 71:386–392CrossRefPubMedGoogle Scholar
  21. 21.
    Langdahl BL, Ralston SH, Grant SF et al. (1998) An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women. J Bone Miner Res 13:1384–1389Google Scholar
  22. 22.
    Hak AE, Polderman KH, Westendorp IC et al. (2000) Increased plasma homocysteine after menopause. Atherosclerosis 149:163–168CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2004

Authors and Affiliations

  • Morten M. Villadsen
    • 1
  • Mathias H. Bünger
    • 1
  • Mette Carstens
    • 1
  • Liselotte Stenkjær
    • 1
  • Bente L. Langdahl
    • 1
  1. 1.Department of Endocrinology and MetabolismAarhus AmtssygehusAarhus CDenmark

Personalised recommendations